Table 2.
Comparison between men and women for PANSS score reduction.
| Amisulpride (n = 52) | Aripiprazole (n = 51) | Olanzapine (n = 41) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Men (n = 25) | Women (n = 27) | p value | Men (n = 39) | Women (n = 12) | p value | Men (n = 29) | Women (n = 12) | p value | |
| PANSS total | −0.59 (0.07) | −0.30 (0.07) | 0.003* | −0.37 (0.07) | −0.53 (0.13) | 0.265 | −0.33 (0.06) | −0.30 (0.11) | 0.776 |
| PANSS positive | −0.20 (0.02) | −0.11 (0.02) | 0.004* | −0.18 (0.02) | −0.21 (0.04) | 0.507 | −0.12 (0.02) | −0.13 (0.04) | 0.789 |
| PANSS negative | −0.10 (0.02) | −0.03 (0.02) | 0.028 | −0.00 (0.02) | −0.06 (0.04) | 0.197 | −0.05 (0.02) | −0.06 (0.04) | 0.812 |
| PANSS general | −0.29 (0.04) | −0.16 (0.04) | 0.014 | −0.19 (0.04) | −0.26 (0.07) | 0.360 | −0.16 (0.03) | −0.11 (0.06) | 0.431 |
Analysis based on linear mixed model with time as continuous variable. PANSS score decrease per week is presented with SE. Differences significant with α = 0.05 are shown in bold. p Values with asterisk (*) remained significant after FDR correction.
n number in the total sample, PANSS Positive and Negative Syndrome Scale.